Towards understanding the role of nanomedicine in targeting TNFR2 in rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the synovium and progressive joint destruction which significantly affects both quality of life and socioeconomic status. Admittedly, various treatments are available, but they are usually accompanied by vario...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Immunology Jg. 173; H. 4; S. 622 - 633
Hauptverfasser:	Lambuk, Fatmawati, Nordin, Nor Asyikin, Mussa, Ali, Lambuk, Lidawani, Ahmad, Suhana, Hassan, Rosline, Kadir, Ramlah, Mohamud, Rohimah, Yahya, Nurul Khaiza
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Wiley Subscription Services, Inc 01.12.2024
Schlagworte:	Animals Antirheumatic Agents - therapeutic use Apoptosis Arthritis Arthritis, Rheumatoid - drug therapy autoimmune disease Autoimmune diseases Control equipment Drug development Health services Humans Inflammation Molecular Targeted Therapy Nanomedicine - methods Nanoparticles Nanoparticles - therapeutic use Nanotechnology Necroptosis Pathophysiology Precision medicine Quality of life Receptors, Tumor Necrosis Factor, Type II - antagonists & inhibitors Receptors, Tumor Necrosis Factor, Type II - metabolism Rheumatoid arthritis Rheumatoid synovitis Side effects Signal Transduction - drug effects Socioeconomics Tumor necrosis factor Tumor necrosis factor receptors Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor Necrosis Factor-alpha - metabolism Tumor necrosis factor-TNF tumour necrosis factor receptor 2 (TNFR2) tumour necrosis factor‐alpha (TNF‐α) nanoparticles autoimmune disease rheumatoid arthritis tumour necrosis factor receptor 2 (TNFR2) tumour necrosis factor‐alpha (TNF‐α) tumour necrosis factor-alpha (TNF-alpha)
ISSN:	0019-2805, 1365-2567, 1365-2567
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!